Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03358238 · ClinicalTrials.gov registry record · NA

Modeling Mood Course to Detect Markers of Effective Adaptive Interventions

A NA study of Bipolar Disorder, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
50
Enrollment target
2
Study locations

NCT03358238 is a NA study of Bipolar Disorder that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 50 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03358238, a NA study of Bipolar Disorder, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
2
Study locations

Study Summary

The goal of this study is to learn how to engage individuals with bipolar disorder in long-term monitoring of daily patterns of mood, stress, sleep, circadian rhythm, and medical adherence. Knowledge gained will be used to develop a mobile health platform for the translation of a psychosocial intervention for bipolar disorder into an effective adaptive intervention.

Conditions Studied

Interventions

  • BEHAVIORAL Weekly review
  • OTHER No weekly review

Study Locations (2)

Michigan

  • University of Michigan - Ann Arbor

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-11-27
Est. Completion 2019-06-19
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT03358238

The ClinicalTrials.gov registry entry for NCT03358238 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (85% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Weekly review is the first listed.

NCT03358238 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT03358238 about?

NCT03358238 is a clinical study titled "Modeling Mood Course to Detect Markers of Effective Adaptive Interventions". The goal of this study is to learn how to engage individuals with bipolar disorder in long-term monitoring of daily patterns of mood, stress, sleep, circadian rhythm, and medical adherence. Knowledge gained will be used to develop a mobile health platform for the translation of a psychosocial interv...

What is the current status of trial NCT03358238?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-11-27. Estimated completion is 2019-06-19.

What conditions does trial NCT03358238 study?

This clinical trial studies the following conditions: Bipolar Disorder.

What interventions are being tested in trial NCT03358238?

The interventions under investigation include: Weekly review (BEHAVIORAL), No weekly review (OTHER).

Who is sponsoring clinical trial NCT03358238?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03358238 being conducted?

This trial has 2 study locations across Michigan, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.